Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Haematologica
|
November 20, 2023
A prospective, multicenter study on hematopoietic stemcell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents
Roberto Mina, Maria Teresa Petrucci, Francesca Bonello, et al.
Journal of Translational Medicine
|
August 7, 2019
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function
Francesca Ulbar, Tiziana Montemurro, Tatiana Jofra, et al.
Cell Reports
|
June 21, 2025
Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors
Francesco Ravera, Martina Dameri, Isabella Lombardo, et al.
Blood Advances
|
December 11, 2024
NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma
Debora Soncini, Pamela Becherini, Francesco Ladisa, et al.
Hemasphere
|
September 4, 2023
Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA
Fabio Efficace, Wael Al Essa, Uwe Platzbecker, et al.
Frontiers in Immunology
|
November 22, 2021
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells
Fabio Guolo, Paola Minetto, Silvia Pesce, et al.
Annals of Hematology
|
January 20, 2025
Impact of calreticulin mutations on treatment and survival outcomes in myelofibrosis during ruxolitinib therapy
Francesca Palandri, Filippo Branzanti, Erika Morsia, et al.
Cancer Medicine
|
October 29, 2019
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis
Enrico Balleari, Rosa Angela Filiberti, Chiara Salvetti, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 18, 2024
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan
Michele Malagola, Alessandra Iurlo, Cristina Bucelli, et al.
Blood Cancer Journal
|
October 7, 2020
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program
Fabio Guolo, Luana Fianchi, Paola Minetto, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Haematologica
|
November 20, 2023
A prospective, multicenter study on hematopoietic stemcell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents
Roberto Mina, Maria Teresa Petrucci, Francesca Bonello, et al.
Journal of Translational Medicine
|
August 7, 2019
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function
Francesca Ulbar, Tiziana Montemurro, Tatiana Jofra, et al.
Cell Reports
|
June 21, 2025
Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors
Francesco Ravera, Martina Dameri, Isabella Lombardo, et al.
Blood Advances
|
December 11, 2024
NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma
Debora Soncini, Pamela Becherini, Francesco Ladisa, et al.
Hemasphere
|
September 4, 2023
Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA
Fabio Efficace, Wael Al Essa, Uwe Platzbecker, et al.
Frontiers in Immunology
|
November 22, 2021
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells
Fabio Guolo, Paola Minetto, Silvia Pesce, et al.
Annals of Hematology
|
January 20, 2025
Impact of calreticulin mutations on treatment and survival outcomes in myelofibrosis during ruxolitinib therapy
Francesca Palandri, Filippo Branzanti, Erika Morsia, et al.
Cancer Medicine
|
October 29, 2019
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis
Enrico Balleari, Rosa Angela Filiberti, Chiara Salvetti, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 18, 2024
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan
Michele Malagola, Alessandra Iurlo, Cristina Bucelli, et al.
Blood Cancer Journal
|
October 7, 2020
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program
Fabio Guolo, Luana Fianchi, Paola Minetto, et al.
Page
of 5